Shashank K Singh Selected Research

Shashank K Singh Research Topics

Disease

25	Neoplasms (Cancer) 03/2024 - 06/2007
4	Colonic Neoplasms (Colon Cancer) 01/2023 - 08/2014
3	Pancreatic Neoplasms (Pancreatic Cancer) 05/2015 - 01/2014
2	Carcinoma (Carcinomatosis) 02/2023 - 06/2007
2	Glioblastoma (Glioblastoma Multiforme) 01/2018 - 01/2013
2	Ovarian Neoplasms (Ovarian Cancer) 11/2017 - 11/2016
2	Ascites 09/2016 - 06/2007
1	Communicable Diseases (Infectious Diseases) 04/2022
1	Erythropoietic Protoporphyria 04/2022
1	Rare Diseases (Rare Disease) 04/2022
1	Interstitial Lung Diseases (Interstitial Lung Disease) 04/2022
1	Giant Cell Tumor of Tendon Sheath 04/2022
1	Sickle Cell Anemia (Hemoglobin S Disease) 04/2022
1	Mental Disorders (Mental Disorder) 04/2022
1	Systemic Scleroderma (Systemic Sclerosis) 04/2022
1	Muscular Dystrophies (Muscular Dystrophy) 04/2022
1	Cystic Fibrosis (Mucoviscidosis) 04/2022
1	Neuromyelitis Optica (Devic's Disease) 04/2022
1	Endocrine System Diseases (Endocrine Diseases) 04/2022
1	Triple Negative Breast Neoplasms 09/2020
1	Melanoma (Melanoma, Malignant) 07/2020
1	Glioma (Gliomas) 01/2018
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 11/2016
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 11/2016
1	Body Weight (Weight, Body) 12/2015
1	Breast Neoplasms (Breast Cancer) 08/2014
1	Leukemia 01/2011
1	Neuroblastoma 06/2007

Drug/Important Bio-Agent (IBA)

5	Gemcitabine FDA Link 09/2016 - 01/2014
4	AcidsIBA 01/2014 - 01/2011
4	boswellic acidIBA 06/2013 - 01/2011
3	Cisplatin (Platino)FDA LinkGeneric 11/2017 - 12/2015
2	lissamine rhodamine B (sulforhodamine B)IBA 03/2024 - 02/2021
1	andrographolideIBA 02/2023
1	Monoclonal AntibodiesIBA 01/2023
1	Raloxifene Hydrochloride (Evista)FDA Link 01/2023
1	Immune Checkpoint ProteinsIBA 01/2023
1	Chalcone (Benzalacetophenone)IBA 09/2022
1	Biosimilar PharmaceuticalsIBA 04/2022
1	PhytochemicalsIBA 03/2022
1	secalonic acidIBA 09/2020
1	neoandrographolideIBA 12/2019
1	EnzymesIBA 12/2019
1	Proteins (Proteins, Gene)FDA Link 12/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2019
1	Caspase 3 (Caspase-3)IBA 12/2019
1	CarbohydratesIBA 12/2019
1	GlycosidesIBA 01/2018
1	DiterpenesIBA 01/2018
1	Clerodane DiterpenesIBA 01/2018
1	ChitosanIBA 01/2018
1	Poly(amidoamine)IBA 01/2018
1	PAMAM StarburstIBA 01/2018
1	Dendrimers (Dendrons)IBA 01/2018
1	Temozolomide (Temodar)FDA LinkGeneric 01/2018
1	Hyaluronic Acid (Hyaluronan)IBA 11/2017
1	Bendamustine Hydrochloride FDA Link 11/2016
1	methoxypolyethyleneglycol- poly(lactic- co- glycolic acid)IBA 09/2016
1	NitrogenIBA 12/2015
1	CreatinineIBA 12/2015
1	Urea (Carbamide)FDA LinkGeneric 12/2015
1	Sulfhydryl Compounds (Thiols)IBA 08/2015
1	Antineoplastic Agents (Antineoplastics)IBA 08/2015
1	MicroRNAs (MicroRNA)IBA 05/2015
1	Nucleoside Transport Proteins (Nucleoside Transporter)IBA 08/2014
1	NucleosidesIBA 08/2014
1	Cytidine DeaminaseIBA 08/2014
1	Paclitaxel (Taxol)FDA LinkGeneric 08/2014
1	Poloxamer (Poloxamer 407)IBA 08/2014
1	Pyruvate KinaseIBA 01/2014
1	thymoquinoneIBA 01/2014
1	Protein Isoforms (Isoforms)IBA 01/2014
1	pyrimidineIBA 01/2013
1	Pentacyclic TriterpenesIBA 07/2012
1	LactonesIBA 08/2011
1	partheninIBA 08/2011
1	NF-kappa B (NF-kB)IBA 08/2011
1	KetonesIBA 08/2011
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 12/2010
1	Podophyllotoxin (Condylox)FDA LinkGeneric 12/2010
1	trioctyl phosphine oxide (TOPO)IBA 12/2010
1	LignansIBA 06/2007
1	Dihydrotachysterol (AT 10)IBA 06/2007
1	matairesinolIBA 06/2007

Therapy/Procedure

5	Therapeutics 04/2022 - 07/2012
3	Drug Therapy (Chemotherapy) 11/2017 - 08/2014
1	Lasers (Laser) 11/2017